Effect of body mass index on prognosis in patients with heart failure and type 2 diabetes
-
摘要: 目的:分析在合并2型糖尿病的慢性心力衰竭(心衰)患者中体质指数(BMI)对预后的影响及肥胖矛盾的存在情况。方法:回顾性分析2014-2015年我院收治的226例合并2型糖尿病的心衰住院患者,根据BMI分为3组:体重正常组(18.5 kg/m2≤BMI<24 kg/m2)、超重组(24 kg/m2≤BMI<28 kg/m2)、肥胖组(BMI≥28 kg/m2),于2016-06-07对患者进行随访。比较各组临床指标、全因死亡及主要不良心血管事件(MACE,包括心源性死亡及心衰再住院)情况。结果:226例患者均完成随访,体重正常组92例,超重组93例,肥胖组41例。发生全因死亡28例(12.4%),发生MACE 101例(44.7%)。其中,体重正常组和肥胖组全因死亡率分别为14.1%(13/92)和12.2%(5/41),均高于超重组的10.8%(10/93)。体重正常组和肥胖组MACE发生率分别为50%(46/92)和58.5%(24/41),均高于超重组的33.3%(32/93),差异有统计学意义(P<0.05)。应用Kaplan-Meier曲线,超重组MACE均低于其他2组(P<0.01),但全因死亡率方面无显著差异(P>0.05)。Cox比例风险回归模型中,与肥胖组患者相比,在调整了其他因素后,体重正常组的MACE[风险比(RR)=0.605,95%可信区间(CI):0.363~1.008,P=0.054]风险降低,超重组MACE(RR=0.430,95%CI:0.251~0.738,P<0.01)风险降低更为明显。结论:肥胖矛盾可能不存在于合并2型糖尿病的心衰人群中,将BMI控制在28 kg/m2以下可能有益于减少不良心血管事件的发生。Abstract: Objective:To evaluate the effect of body mass index(BMI) on the prognosis of patients with chronic heart failure(CHF) and type 2 diabetes(T2DM), and to explore the existence of the obesity paradox. Method:A total of 226 patients with CHF and T2DM in our hospital from 2014 to 2015 were included in this retrospective study. Patients were divided into 3 groups according to their BMI:normal weight group (18.5 kg/m2≤BMI<24.0 kg/m2),overweight group (24 kg/m2≤BMI<28 kg/m2) and obese group (BMI≥28 kg/m2). Followed-up was completed from June to July,2016.We analyzed the clinical parameters, the all-cause mortality and the major adverse cardiovascular events(MACE),including cardiac death and rehospitalization for heart failure from these groups. Result:A total of 226 patients were finished during follow up (92 in normal weight group,93 in overweight group and 41 in obesity group).There were 28 cases of (12.4%) all-cause deaths and 101 cases (44.7%) of MACE.Incidence of all-cause mortality in the normal weight group 14.1%(13/92)and in the obese group 12.2%(5/41), was both higher than that in the overweight group 10.8%(10/93)(P=0.784).Similarly, the incidence of MACE in the normal weight group 50%(46/92)and in the obese group 58.5%(24/41),was also both higher than that in the overweight group 33.3%(32/93)(P<0.05).Kaplan-Meier curves showed the incidence of MACE were lower in the overweight group than that in the other two groups(P<0.01). There was no difference in the all-cause mortality among three groups (P=0.824).Multivariate Cox regression model showed normal weight patients had decreased risk for MACE(RR=0.605,95%CI:0.363~1.008,P=0.054) compared with patients of obesity group.Overweight patients had more obvious decreased risk for MACE(RR=0.430,95%CI: weight patients had decreased risk for MACE(RR=0.605,95%CI:0.363~1.008,P=0.054) compared with patients of obesity group.Overweight patients had more obvious decreased risk for MACE(RR=0.430,95%CI:0.251~0.738,P<0.01).Conclusion:The obesity paradox may absence in patients with CHF and T2DM. BMI control under 28 kg/m2 may help reduce the incidence of MACE.
-
Key words:
- obesity paradox /
- body mass index /
- type 2 diabetes /
- heart failure
-
[1] KENCHAIAH S,EVANS J C,LEVY D,et al.Obesity and the risk of heart failure[J].N Eng J Med,2002,47:305-313.
[2] KALANTAR-ZADEH K,BLOCK G,HORWICH T,et al.Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure[J].J Am Coll Cardiol,2004,43:1439-1444.
[3] KENCHAIAH S,POCOCK S J,WANG D,et al.Body mass index and prognosis in patients with chronic heart failure:insights from the Candesartan in Heart failure:Assessment of Reduction in Mortality and morbidity(CHARM)program[J].Circulation,2007,116:627-636.
[4] SHARMA A,LAVIE C J,BORER J S,et al.Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure[J].Am J Cardiol,2015,115:1428-1434.
[5] MACDONALD M R,PETRIE M C,VARYANI F,et al.Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure[J].European Heart Journal,2008,29:1377-1385.
[6] ADAMOPOULOS C,MEYER P,DESAI R V,et al.Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus:a propensitymatched study[J].Eur J Heart Fail,2011,13:200-206.
[7] PINHO E M,LOURENCO P,SILVA S,et al.Higher BMI in heart failure patients is associated with longer survival only in the absence of diabetes[J].J Cardiovasc Med,2015,16:576-582.
[8] WARING M E,SACZYNSKI J S,MCMANUS D,et al.Weight and mortality following heart failure hospitalization among diabetic patients[J].Am J Med,2011,124:834-840.
[9] DICKSTEIN K,COHEN-SOLAL A,FILIPPATOS G,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC(HFA)and endorsed by the European Society of Intensive Care Medicine(ESICM)[J].Eur Heart J,2008,29:2388-2442.
[10] ALBERTI K G,ZIMMET P Z.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15:539-553.
[11] 中国肥胖问题工作组.中国成人超重与肥胖症预防与控制指南(节录)[J].营养学报,2004,26(1):1-4.
[12] TRESCH D D,MCGOUGH M F.Heart failure with normal systolic function:a common disorder in older people[J].J Am Geriatr Soc,1995,43:1035-1042.
[13] 吕宪玉,刘聚伟,秦浩,等.老年舒张性心力衰竭的常见病因分析[J].中华保健医学杂志,2009,11(2):96-98.
[14] FUTTER J E,CLELAND J G,CLARK A L.Body mass indices and outcome in patients with chronic heart failure[J].Eur J of Heart Fail,2011,13:207-213.
计量
- 文章访问数: 166
- PDF下载数: 70
- 施引文献: 0